ID   DUOX1_HUMAN             Reviewed;        1551 AA.
AC   Q9NRD9; A6NH28; Q14C94; Q6ZMB3; Q6ZR09; Q9NZC1;
DT   21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=Dual oxidase 1;
DE            EC=1.11.1.-;
DE            EC=1.6.3.1;
DE   AltName: Full=Large NOX 1;
DE   AltName: Full=Long NOX 1;
DE   AltName: Full=NADPH thyroid oxidase 1;
DE   AltName: Full=Thyroid oxidase 1;
DE   Flags: Precursor;
GN   Name=DUOX1; Synonyms=DUOX, LNOX1, THOX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RC   TISSUE=Thyroid;
RX   PubMed=10806195; DOI=10.1074/jbc.M000916200;
RA   De Deken X., Wang D., Many M.-C., Costagliola S., Libert F.,
RA   Vassart G., Dumont J.E., Miot F.;
RT   "Cloning of two human thyroid cDNAs encoding new members of the NADPH
RT   oxidase family.";
RL   J. Biol. Chem. 275:23227-23233(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT PHE-1178, FUNCTION,
RP   CATALYTIC ACTIVITY, ENZYME REGULATION, DEVELOPMENTAL STAGE, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=11514595; DOI=10.1083/jcb.200103132;
RA   Edens W.A., Sharling L., Cheng G., Shapira R., Kinkade J.M., Lee T.,
RA   Edens H.A., Tang X., Sullards C., Flaherty D.B., Benian G.M.,
RA   Lambeth J.D.;
RT   "Tyrosine cross-linking of extracellular matrix is catalyzed by Duox,
RT   a multidomain oxidase/peroxidase with homology to the phagocyte
RT   oxidase subunit gp91phox.";
RL   J. Cell Biol. 154:879-891(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1030-1551 (ISOFORMS 1/2), AND VARIANT
RP   ARG-1026.
RC   TISSUE=Lung, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   GLYCOSYLATION.
RX   PubMed=11822874; DOI=10.1006/excr.2001.5444;
RA   De Deken X., Wang D., Dumont J.E., Miot F.;
RT   "Characterization of ThOX proteins as components of the thyroid
RT   H(2)O(2)-generating system.";
RL   Exp. Cell Res. 273:187-196(2002).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12824283; DOI=10.1096/fj.02-1104fje;
RA   Geiszt M., Witta J., Baffi J., Lekstrom K., Leto T.L.;
RT   "Dual oxidases represent novel hydrogen peroxide sources supporting
RT   mucosal surface host defense.";
RL   FASEB J. 17:1502-1504(2003).
RN   [8]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15210697; DOI=10.1074/jbc.M404983200;
RA   Schwarzer C., Machen T.E., Illek B., Fischer H.;
RT   "NADPH oxidase-dependent acid production in airway epithelial cells.";
RL   J. Biol. Chem. 279:36454-36461(2004).
RN   [9]
RP   INDUCTION.
RX   PubMed=16111680; DOI=10.1016/j.febslet.2005.08.002;
RA   Harper R.W., Xu C., Eiserich J.P., Chen Y., Kao C.-Y., Thai P.,
RA   Setiadi H., Wu R.;
RT   "Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and
RT   Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium.";
RL   FEBS Lett. 579:4911-4917(2005).
RN   [10]
RP   INTERACTION WITH TXNDC11; TPO AND CYBA.
RX   PubMed=15561711; DOI=10.1074/jbc.M407709200;
RA   Wang D., De Deken X., Milenkovic M., Song Y., Pirson I., Dumont J.E.,
RA   Miot F.;
RT   "Identification of a novel partner of duox: EFP1, a thioredoxin-
RT   related protein.";
RL   J. Biol. Chem. 280:3096-3103(2005).
RN   [11]
RP   CATALYTIC ACTIVITY, AND ENZYME REGULATION.
RX   PubMed=15972824; DOI=10.1074/jbc.M500516200;
RA   Ameziane-El-Hassani R., Morand S., Boucher J.L., Frapart Y.-M.,
RA   Apostolou D., Agnandji D., Gnidehou S., Ohayon R., Noel-Hudson M.-S.,
RA   Francon J., Lalaoui K., Virion A., Dupuy C.;
RT   "Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating
RT   activity.";
RL   J. Biol. Chem. 280:30046-30054(2005).
CC   -!- FUNCTION: Generates hydrogen peroxide which is required for the
CC       activity of thyroid peroxidase/TPO and lactoperoxidase/LPO. Plays
CC       a role in thyroid hormones synthesis and lactoperoxidase-mediated
CC       antimicrobial defense at the surface of mucosa. May have its own
CC       peroxidase activity through its N-terminal peroxidase-like domain.
CC       {ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:12824283}.
CC   -!- CATALYTIC ACTIVITY: NAD(P)H + O(2) = NAD(P)(+) + H(2)O(2).
CC       {ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:15972824}.
CC   -!- ENZYME REGULATION: The NADPH oxidase activity is calcium-
CC       dependent. Peroxidase activity is inhibited by
CC       aminobenzohydrazide. {ECO:0000269|PubMed:11514595,
CC       ECO:0000269|PubMed:15972824}.
CC   -!- PATHWAY: Hormone biosynthesis; thyroid hormone biosynthesis.
CC   -!- SUBUNIT: Interacts with TXNDC11, TPO and CYBA.
CC       {ECO:0000269|PubMed:15561711}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:10806195, ECO:0000269|PubMed:15210697}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:10806195,
CC       ECO:0000269|PubMed:15210697}. Note=Localizes to the apical
CC       membrane of epithelial cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NRD9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRD9-2; Sequence=VSP_017262, VSP_017263;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in thyrocytes and tracheal surface
CC       epithelial cells (at protein level). Expressed in thyroid,
CC       trachea, bronchium, and to a lower extent, in placenta, testis,
CC       prostate, pancreas and heart. {ECO:0000269|PubMed:10806195,
CC       ECO:0000269|PubMed:11514595, ECO:0000269|PubMed:12824283,
CC       ECO:0000269|PubMed:15210697}.
CC   -!- DEVELOPMENTAL STAGE: Widely expressed in fetal tissues.
CC       {ECO:0000269|PubMed:11514595}.
CC   -!- INDUCTION: By forskolin (at protein level). By thyrotropin and the
CC       Th2-specific cytokines IL-4 and IL-13.
CC       {ECO:0000269|PubMed:10806195, ECO:0000269|PubMed:16111680}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11822874}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the peroxidase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK128591; Type=Erroneous termination; Positions=967; Note=Translated as Arg.; Evidence={ECO:0000305};
CC       Sequence=BAD18816.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF230495; AAF73921.1; -; mRNA.
DR   EMBL; AF213465; AAF71295.1; -; mRNA.
DR   EMBL; AK128591; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK172859; BAD18816.1; ALT_INIT; mRNA.
DR   EMBL; AC051619; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC114628; AAI14629.1; -; mRNA.
DR   CCDS; CCDS32221.1; -. [Q9NRD9-1]
DR   RefSeq; NP_059130.2; NM_017434.4. [Q9NRD9-1]
DR   RefSeq; NP_787954.1; NM_175940.2. [Q9NRD9-1]
DR   RefSeq; XP_011519984.1; XM_011521682.1. [Q9NRD9-2]
DR   UniGene; Hs.272813; -.
DR   ProteinModelPortal; Q9NRD9; -.
DR   IntAct; Q9NRD9; 2.
DR   STRING; 9606.ENSP00000317997; -.
DR   PeroxiBase; 3339; HsDuOx01.
DR   TCDB; 5.B.1.1.6; the phagocyte (gp91(phox)) nadph oxidase family.
DR   iPTMnet; Q9NRD9; -.
DR   PhosphoSitePlus; Q9NRD9; -.
DR   BioMuta; DUOX1; -.
DR   DMDM; 74719102; -.
DR   EPD; Q9NRD9; -.
DR   MaxQB; Q9NRD9; -.
DR   PaxDb; Q9NRD9; -.
DR   PeptideAtlas; Q9NRD9; -.
DR   PRIDE; Q9NRD9; -.
DR   Ensembl; ENST00000321429; ENSP00000317997; ENSG00000137857. [Q9NRD9-1]
DR   Ensembl; ENST00000389037; ENSP00000373689; ENSG00000137857. [Q9NRD9-1]
DR   Ensembl; ENST00000561166; ENSP00000454065; ENSG00000137857. [Q9NRD9-2]
DR   GeneID; 53905; -.
DR   KEGG; hsa:53905; -.
DR   UCSC; uc001zus.3; human. [Q9NRD9-1]
DR   CTD; 53905; -.
DR   DisGeNET; 53905; -.
DR   GeneCards; DUOX1; -.
DR   HGNC; HGNC:3062; DUOX1.
DR   HPA; HPA023544; -.
DR   MIM; 606758; gene.
DR   neXtProt; NX_Q9NRD9; -.
DR   OpenTargets; ENSG00000137857; -.
DR   PharmGKB; PA27516; -.
DR   eggNOG; KOG0039; Eukaryota.
DR   eggNOG; ENOG410XNZY; LUCA.
DR   GeneTree; ENSGT00550000074350; -.
DR   HOGENOM; HOG000231774; -.
DR   HOVERGEN; HBG080428; -.
DR   InParanoid; Q9NRD9; -.
DR   KO; K13411; -.
DR   OMA; DVFMWRT; -.
DR   OrthoDB; EOG091G00PO; -.
DR   PhylomeDB; Q9NRD9; -.
DR   TreeFam; TF105424; -.
DR   BRENDA; 1.6.3.1; 2681.
DR   Reactome; R-HSA-209968; Thyroxine biosynthesis.
DR   SABIO-RK; Q9NRD9; -.
DR   SIGNOR; Q9NRD9; -.
DR   UniPathway; UPA00194; -.
DR   GeneWiki; Dual_oxidase_1; -.
DR   GenomeRNAi; 53905; -.
DR   PRO; PR:Q9NRD9; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000137857; -.
DR   CleanEx; HS_DUOX1; -.
DR   ExpressionAtlas; Q9NRD9; baseline and differential.
DR   Genevisible; Q9NRD9; HS.
DR   GO; GO:0016324; C:apical plasma membrane; NAS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0016174; F:NAD(P)H oxidase activity; TAS:Reactome.
DR   GO; GO:0050661; F:NADP binding; NAS:UniProtKB.
DR   GO; GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0042335; P:cuticle development; IMP:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0050665; P:hydrogen peroxide biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0055114; P:oxidation-reduction process; TAS:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   GO; GO:0042554; P:superoxide anion generation; NAS:UniProtKB.
DR   GO; GO:0006590; P:thyroid hormone generation; TAS:Reactome.
DR   CDD; cd00051; EFh; 2.
DR   Gene3D; 1.10.640.10; -; 1.
DR   InterPro; IPR029595; DUOX1/Duox.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013112; FAD-bd_8.
DR   InterPro; IPR017927; Fd_Rdtase_FAD-bd.
DR   InterPro; IPR013130; Fe3_Rdtase_TM_dom.
DR   InterPro; IPR013121; Fe_red_NAD-bd_6.
DR   InterPro; IPR010255; Haem_peroxidase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR11972:SF86; PTHR11972:SF86; 1.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   Pfam; PF00036; EF-hand_1; 2.
DR   Pfam; PF08022; FAD_binding_8; 1.
DR   Pfam; PF01794; Ferric_reduct; 1.
DR   Pfam; PF08030; NAD_binding_6; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Complete proteome; FAD;
KW   Flavoprotein; Glycoprotein; Hydrogen peroxide; Membrane;
KW   Metal-binding; NADP; Oxidoreductase; Peroxidase; Polymorphism;
KW   Reference proteome; Repeat; Signal; Thyroid hormones biosynthesis;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22   1551       Dual oxidase 1.
FT                                /FTId=PRO_0000223344.
FT   TOPO_DOM     22    596       Extracellular. {ECO:0000255}.
FT   TRANSMEM    597    617       Helical. {ECO:0000255}.
FT   TOPO_DOM    618   1044       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1045   1065       Helical. {ECO:0000255}.
FT   TOPO_DOM   1066   1080       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1081   1101       Helical. {ECO:0000255}.
FT   TOPO_DOM   1102   1148       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1149   1171       Helical. {ECO:0000255}.
FT   TOPO_DOM   1172   1188       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1189   1209       Helical. {ECO:0000255}.
FT   TOPO_DOM   1210   1226       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1227   1247       Helical. {ECO:0000255}.
FT   TOPO_DOM   1248   1248       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1249   1269       Helical. {ECO:0000255}.
FT   TOPO_DOM   1270   1551       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      815    850       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      851    886       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      895    930       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN     1087   1269       Ferric oxidoreductase.
FT   DOMAIN     1270   1376       FAD-binding FR-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00716}.
FT   CA_BIND     828    839       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     864    875       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   REGION       26    593       Peroxidase-like; mediates peroxidase
FT                                activity.
FT   REGION      956   1248       Interaction with TXNDC11. {ECO:0000250}.
FT   CARBOHYD     94     94       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    354    354       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    461    461       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    534    534       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    354       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017262.
FT   VAR_SEQ     355    405       SSVSRALRVCNSYWSREHPSLQSAEDVDALLLGMASQIAER
FT                                EDHVLVEDVR -> MWMHCCWAWPPRSQSERTMCWLKMCGV
FT                                SLRLSLQVVNSWPLGRGSAGLPEP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_017263.
FT   VARIANT     962    962       I -> T (in dbSNP:rs16939743).
FT                                /FTId=VAR_049104.
FT   VARIANT    1026   1026       C -> R (in dbSNP:rs16939752).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_025321.
FT   VARIANT    1178   1178       L -> F (in dbSNP:rs2458236).
FT                                {ECO:0000269|PubMed:11514595}.
FT                                /FTId=VAR_025322.
FT   CONFLICT    413    413       K -> E (in Ref. 3; AK128591).
FT                                {ECO:0000305}.
FT   CONFLICT   1388   1388       G -> R (in Ref. 3; BAD18816).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1551 AA;  177235 MW;  37CF124A579446B0 CRC64;
     MGFCLALAWT LLVGAWTPLG AQNPISWEVQ RFDGWYNNLM EHRWGSKGSR LQRLVPASYA
     DGVYQPLGEP HLPNPRDLSN TISRGPAGLA SLRNRTVLGV FFGYHVLSDL VSVETPGCPA
     EFLNIRIPPG DPMFDPDQRG DVVLPFQRSR WDPETGRSPS NPRDPANQVT GWLDGSAIYG
     SSHSWSDALR SFSRGQLASG PDPAFPRDSQ NPLLMWAAPD PATGQNGPRG LYAFGAERGN
     REPFLQALGL LWFRYHNLWA QRLARQHPDW EDEELFQHAR KRVIATYQNI AVYEWLPSFL
     QKTLPEYTGY RPFLDPSISS EFVAASEQFL STMVPPGVYM RNASCHFQGV INRNSSVSRA
     LRVCNSYWSR EHPSLQSAED VDALLLGMAS QIAEREDHVL VEDVRDFWPG PLKFSRTDHL
     ASCLQRGRDL GLPSYTKARA ALGLSPITRW QDINPALSRS NDTVLEATAA LYNQDLSWLE
     LLPGGLLESH RDPGPLFSTI VLEQFVRLRD GDRYWFENTR NGLFSKKEIE EIRNTTLQDV
     LVAVINIDPS ALQPNVFVWH KGDPCPQPRQ LSTEGLPACA PSVVRDYFEG SGFGFGVTIG
     TLCCFPLVSL LSAWIVARLR MRNFKRLQGQ DRQSIVSEKL VGGMEALEWQ GHKEPCRPVL
     VYLQPGQIRV VDGRLTVLRT IQLQPPQKVN FVLSSNRGRR TLLLKIPKEY DLVLLFNLEE
     ERQALVENLR GALKESGLSI QEWELREQEL MRAAVTREQR RHLLETFFRH LFSQVLDINQ
     ADAGTLPLDS SQKVREALTC ELSRAEFAES LGLKPQDMFV ESMFSLADKD GNGYLSFREF
     LDILVVFMKG SPEEKSRLMF RMYDFDGNGL ISKDEFIRML RSFIEISNNC LSKAQLAEVV
     ESMFRESGFQ DKEELTWEDF HFMLRDHNSE LRFTQLCVKG VEVPEVIKDL CRRASYISQD
     MICPSPRVSA RCSRSDIETE LTPQRLQCPM DTDPPQEIRR RFGKKVTSFQ PLLFTEAHRE
     KFQRSCLHQT VQQFKRFIEN YRRHIGCVAV FYAIAGGLFL ERAYYYAFAA HHTGITDTTR
     VGIILSRGTA ASISFMFSYI LLTMCRNLIT FLRETFLNRY VPFDAAVDFH RLIASTAIVL
     TVLHSVGHVV NVYLFSISPL SVLSCLFPGL FHDDGSELPQ KYYWWFFQTV PGLTGVVLLL
     ILAIMYVFAS HHFRRRSFRG FWLTHHLYIL LYVLLIIHGS FALIQLPRFH IFFLVPAIIY
     GGDKLVSLSR KKVEISVVKA ELLPSGVTHL RFQRPQGFEY KSGQWVRIAC LALGTTEYHP
     FTLTSAPHED TLSLHIRAAG PWTTRLREIY SAPTGDRCAR YPKLYLDGPF GEGHQEWHKF
     EVSVLVGGGI GVTPFASILK DLVFKSSVSC QVFCKKIYFI WVTRTQRQFE WLADIIREVE
     ENDHQDLVSV HIYITQLAEK FDLRTTMLYI CERHFQKVLN RSLFTGLRSI THFGRPPFEP
     FFNSLQEVHP QVRKIGVFSC GPPGMTKNVE KACQLINRQD RTHFSHHYEN F
//
